Gene · 2801
GOLGA2: golgin A2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GOLGA2: golgin A2. Genes, record 2801. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2801
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q08379 | Golgin subfamily A member 2 | 1,002 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents11
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 18368 | Q08379 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 22825 | Q08379 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 22825 | Q08379 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18368 | Q08379 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 35980 | Q08379 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 35983 | Q08379 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 138951 | Q08379 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 138954 | Q08379 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 4575 | Q08379 | Espacenet |
| JP 2017121240 A | 2017-07-13 | 50695 | Q08379 | Espacenet |
1 to 10 of 11
See all 11 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,555
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GOLGA2 papers | Newest fiscal year |
|---|---|---|---|
| R01GM083144 | Characterization of mammalian COG complex-interacting Golgi trafficking machinery | 24 | 2025 |
| P30DK045735 | Yale Diabetes Research Center | 13 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 12 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 12 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 11 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 10 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30DK020593 | Vanderbilt Diabetes Research Center | 8 | 2025 |
| R37GM058615 | Mechanisms and Physiology of COPI Transport | 7 | 2025 |
| P20GM121176 | Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2. | 6 | 2025 |
1 to 10 of 2,555Source NIH's project files
See all 2,555 nih grantsPapers3,432
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-cycle-resolved τSTED nanoscopy reveals nanoscale reorganization of TGN46-positive structures. | Cell Struct Funct | 2026 | 42732940 | PubTator, text mining | PubMed |
| Vibration reduces transcript levels of the Golgi-associated gene GOLGA2 in HeLa cells. | MicroPubl Biol | 2026 | 42657077 | PubTator, text mining | PubMed |
| COPI Coatomer Regulates Several Steps of HDL Metabolism. | Arterioscler Thromb Vasc Biol | 2026 | 42592650 | PubTator, text mining | PubMed |
| Alu-mediated SPAST deletion impairs golgi zinc transport and reveals a druggable vulnerability. | Signal Transduct Target Ther | 2026 | 42521669 | PubTator, text mining | PubMed |
| Systematic reanalysis of next-generation sequencing data in 101 neuromuscular disorder families enhances diagnostic yield, reveals intronic variants, and identifies a novel disease gene. | J Neurol | 2026 | 42474733 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism. | Cell Rep | 2026 | 42287635 | PubTator, text mining | PubMed |
| Hyperosmotic stress-induced redistribution of pre-mRNA cleavage factor I subunits is associated with shifts in alternative polyadenylation. | FEBS Open Bio | 2026 | 42244075 | PubTator, text mining | PubMed |
| B3GNT7 preserves intestinal barrier integrity: a key defense mechanism against acute pancreatitis progression. | Clin Exp Med | 2026 | 42218343 | PubTator, text mining | PubMed |
| Mitochondria-lysosome coupling contributes to lysosome acidification and aging. | Mol Cell | 2026 | 42214330 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk transcriptomics identify autophagy-related immune-suppressive subtypes and a prognostic signature in colorectal cancer. | Front Immunol | 2026 | 42093974 | PubTator, text mining | PubMed |
1 to 10 of 3,432
See all 3,432 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2801
GET https://conductscience.org/api/genes/v1/2801/patents